Adage Capital Partners’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-46,343
| Closed | -$11.4M | – | 1085 |
|
|
2022
Q3 | $11.4M | Sell |
46,343
-1,100
| -2% | -$270K | 0.03% | 601 |
|
|
2022
Q2 | $11.7M | Sell |
47,443
-100,100
| -68% | -$24.8M | 0.03% | 631 |
|
|
2022
Q1 | $48.9M | Sell |
147,543
-25,900
| -15% | -$8.58M | 0.09% | 218 |
|
|
2021
Q4 | $62.3M | Buy |
173,443
+125,100
| +259% | +$44.9M | 0.11% | 184 |
|
|
2021
Q3 | $15.7M | Buy |
48,343
+29,300
| +154% | +$9.54M | 0.03% | 550 |
|
|
2021
Q2 | $5.94M | Sell |
19,043
-151,200
| -89% | -$47.2M | 0.01% | 797 |
|
|
2021
Q1 | $54.3M | Buy |
170,243
+20,100
| +13% | +$6.41M | 0.11% | 197 |
|
|
2020
Q4 | $48.7M | Buy |
150,143
+49,830
| +50% | +$16.2M | 0.11% | 205 |
|
|
2020
Q3 | $27.8M | Sell |
100,313
-76,700
| -43% | -$21.3M | 0.07% | 296 |
|
|
2020
Q2 | $42.8M | Buy |
177,013
+6,101
| +4% | +$1.47M | 0.11% | 212 |
|
|
2020
Q1 | $24.8M | Buy |
+170,912
| New | +$24.8M | 0.07% | 278 |
|
|
2019
Q3 | – | Sell |
-36,860
| Closed | -$9.6M | – | 772 |
|
|
2019
Q2 | $9.6M | Sell |
36,860
-19,800
| -35% | -$5.16M | 0.02% | 538 |
|
|
2019
Q1 | $16.2M | Buy |
56,660
+644
| +1% | +$184K | 0.04% | 435 |
|
|
2018
Q4 | $18.2M | Buy |
56,016
+21,416
| +62% | +$6.96M | 0.05% | 357 |
|
|
2018
Q3 | $15.6M | Sell |
34,600
-16,800
| -33% | -$7.56M | 0.03% | 466 |
|
|
2018
Q2 | $21M | Buy |
+51,400
| New | +$21M | 0.05% | 388 |
|
|
2014
Q1 | – | Sell |
-184,532
| Closed | -$4.93M | – | 746 |
|
|
2013
Q4 | $4.93M | Sell |
184,532
-143,568
| -44% | -$3.84M | 0.01% | 588 |
|
|
2013
Q3 | $6.25M | Sell |
328,100
-200,000
| -38% | -$3.81M | 0.02% | 561 |
|
|
2013
Q2 | $11.4M | Buy |
+528,100
| New | +$11.4M | 0.04% | 471 |
|